Refex Life Sciences Private Limited, a active private limited company, was established on 03 March 2021 in Chennai, Tamil Nadu, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U33112TN2021PTC141761. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹210.00 Cr and a paid-up capital of ₹91.63 Cr.
It upholds a compliant status. Its leadership includes Patrik Vijay Kumar Francis Arun Kumar (Director), Dinesh Kumar Agarwal (Director). Past directors included Pasupathy Puthuseri Veedu, Chandresh Jain, Patrik Vijay Kumar Francis Arun Kumar. It holds ₹460.00 Cr open charges and no settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Second Floor, Refex Towers, Sterling Road Signal, 313, Valluvar Kottam High Road, Nungambakkam, Chennai, Tamil Nadu, 600034.
U33112TN2021PTC141761
141761
03 March 2021
₹210.00 Cr
₹91.63 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Refex Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Patrik Vijay Kumar Francis Arun Kumar | Director | 05 Oct 2022 | Current |
| Dinesh Kumar Agarwal | Director | 03 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Jun 2024 | Past |
| Pramod Abcsdd | Director | 05 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2023 | Past |
| Pramod Abcsdd | Director | 07 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Anam Fine Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 161.66% increase. The company also saw a substantial fall in profitability, with a 7938% decrease in profit. The company's net worth Soared by an impressive increase of 6659.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Refex Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,600,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2025 | Others | ₹335.00 Cr | Open |
| 17 May 2023 | Others | ₹125.00 Cr | Open |
Explore comprehensive loan charge details -
Refex Life Sciences has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Refex Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Refex Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 335.00 Cr with Charge ID 101161332 was registered on 30 Jul 2025. was recorded as a recent event.
The activity Praveen Kumar was appointed as a Company Secretary was appointed as a Company Secretary on 31 May 2025 & has been associated with this company since 5 months 26 days . was completed.
Progress on Refex Life Sciences Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was documented.
The activity Refex Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
Progress on A charge with Others of Rs. 125.00 Cr registered on 17 May 2023 with Charge ID 100720123 was modified on 09 Jun 2023. was documented.
A charge with Others amounted to Rs. 125.00 Cr with Charge ID 100720123 was registered on 17 May 2023. was recorded as a recent event.
The CIN of Refex Life Sciences Private Limited is U33112TN2021PTC141761.
Refex Life Sciences Private Limited is headquartered at Second Floor, Refex Towers, Sterling Road Signal, 313, Valluvar Kottam High Road, Nungambakkam, Chennai, Tamil Nadu, 600034.
Refex Life Sciences Private Limited was incorporated on 03 March 2021.
The current directors of Refex Life Sciences Private Limited are
The primary industry of Refex Life Sciences Private Limited is Manufacturing.
Refex Life Sciences Private Limited is unlisted.
The authorized capital of Refex Life Sciences Private Limited is ₹210.00 Cr, and the paid-up capital is ₹91.63 Cr.
The compliance status of Refex Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX